This is a computer translation of the original webpage. It is provided for general information only and should not be regarded as complete nor accurate. Close Disclaimer
Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Inflation Reduction Act Research Series: Medicare Part D Enrollee Vaccine Use After Elimination of Cost Sharing for Recommended Vaccines in 2023

Publication Date
Authors
Bisma A. Sayed, Yevgeniy Feyman, Kristen L. King, Kenneth Finegold, Rachael Zuckerman, Steven Sheingold, Nancy De Lew, Thomas Buchmueller

Effective January 1, 2023, the Inflation Reduction Act (IRA) eliminated cost sharing and deductibles for adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) covered under Medicare Part D. In 2023, 10.3 million Medicare Part D enrollees received a recommended vaccine free of charge, which saved enrollees more than $400 million in out-of-pocket costs. The majority of enrollees who received vaccines did for the prevention of respiratory syncytial virus (RSV), followed by shingles.

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Bisma Sayed, (202) 617-7098, bisma.sayed@hhs.gov. Content will be updated pending the outcome of the Section 508 review.

Related Products

Product Type
ASPE Data Point
Populations
Older Adults | | Racial & Ethnic Groups | | End of
Translation
Click to Translate text after this point
Medicare Beneficiaries
Location- & Geography-Based Data
National Data | State Data
Program
Medicare | Medicare Part D